Pulmonary arterial hypertension and its association with HIV infection: an overview
HIV epidemiology and the effects of antiviral therapy on long-term consequences
The role of secondary lymphatic tissue in immune deficiency of HIV infection
Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors
Vasculitides in the context of HIV infection
Natural history of HIV-associated pulmonary arterial hypertension: trends in the HAART era
Mediators involved in HIV-related pulmonary arterial hypertension
From viral infection to pulmonary arterial hypertension: a role for viral proteins?
HIV-related pulmonary arterial hypertension: clinical presentation and management
Editors' perspective and conclusions